首页> 外文期刊>Malaria Journal >Diagnostic performance of CareStart? malaria HRP2/pLDH (Pf/pan) combo test versus standard microscopy on falciparum and vivax malaria between China-Myanmar endemic borders
【24h】

Diagnostic performance of CareStart? malaria HRP2/pLDH (Pf/pan) combo test versus standard microscopy on falciparum and vivax malaria between China-Myanmar endemic borders

机译:CareStart的诊断性能?疟疾HRP2 / pLDH(Pf / pan)组合测试与标准显微镜在中缅流行边界之间进行的恶性疟和间日疟的比较

获取原文
           

摘要

Background Rapid diagnostic test (RDT) is becoming an alternative way of establishing quickly the diagnosis of malaria infections, by detecting specific malaria antigens in suspected patients’ blood between the China-Myanmar endemic borders areas, towards achieving the National Malaria Elimination programme by 2020. The objective of this study is to evaluate the performance of CareStart? Malaria Pf/Pan RDT kit for the diagnosis of malaria infections in suspected patients. Blood examination by microscopy was taken as gold standard to evaluate CareStart? kit’s sensitivity, specificity and predictive value and corrected with PCR assay. Results Overall 126 of 241 (52.28%) malaria cases were detected by microscopy compared to 115 of 241(47.72%) CareStart? kit and 128 of 241 (53.11%) PCR corrected assay. CareStart? kit’s sensitivity and specificity for the diagnosis of malaria were 89.68% and 98.26% respectively, compared to standard microscopy, whereas the sensitivity and specificity for falciparum malaria were 88.52% and 98.26%, and for vivax malaria: 90.77% and 100%. The CareStart? positive predictive values were 98.26% (93.88-99.52%, 95% CI) compared to 100% (96.77-100%, 95% CI) for PCR-corrected, and the negative predictive values of 89.68% (83.15-93.87%, 95% CI) were the same in microscopy as PCR-corrected. The diagnostic accuracy of CareStart? kit versus microscopy and PCR were 93.78% (89.99-96.19%, 95% CI) and 94.61% (90.99-96.82%, 95% CI) respectively. The likelihood of diagnostic of malaria positive was almost similar between microscopy and CareStart? kit, with an entropy reduction of 60.0% compared to a weak likelihood of misdiagnosis of 0.10 (0.09-0.12, 95% CI), with an entropy reduction of 36.01%. Conclusion The accuracy of CareStart? kit is comparable to gold standard microscopy in these areas, it is easy to perform and suitable for cross-border diagnosis and monitoring of local or imported malaria patterns by any local health staff in endemic remotes.
机译:背景技术快速诊断测试(RDT)通过在中缅流行地区之间检测可疑患者血液中的特定疟疾抗原,正在迅速建立疟疾感染的替代方法,以在2020年之前实现“消除疟疾全国计划”。这项研究的目的是评估CareStart的性能。疟疾Pf / Pan RDT试剂盒,用于诊断可疑患者的疟疾感染。显微镜检查血液被视为评估CareStart的金标准。试剂盒的敏感性,特异性和预测价值,并通过PCR测定法进行了校正。结果显微镜检查发现241例疟疾病例中的126例(52.28%),而241例中115例(47.72%)。试剂盒和241个PCR校正分析中的128个(53.11%)。 CareStart?与标准显微镜相比,该试剂盒对疟疾诊断的敏感性和特异性分别为89.68%和98.26%,而对恶性疟疾的敏感性和特异性分别为88.52%和98.26%和间日疟疾的敏感性和特异性分别为90.77%和100%。 CareStart?阳性预测值为98.26%(93.88-99.52%,95%CI),而经PCR校正的阳性预测值为100%(96.77-100%,95%CI),阴性预测值为89.68%(83.15-93.87%,95) %CI)在显微镜下与PCR校正的相同。 CareStart的诊断准确性?试剂盒,显微镜和PCR分别为93.78%(89.99-96.19%,95%CI)和94.61%(90.99-96.82%,95%CI)。在显微镜和CareStart之间,诊断出疟疾阳性的可能性几乎相似。试剂盒,熵降低了60.0%,而误诊的可能性很低,为0.10(0.09-0.12,95%CI),熵降低了36.01%。结论CareStart的准确性?在这些区域,该试剂盒可与金标准显微镜相媲美,它易于执行,并且适合任何地方性偏远地区的本地卫生人员进行跨境诊断和监测本地或进口疟疾模式。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号